Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | TSM | META |
|---|---|---|
| Price | $448.58 | $770.26 |
| Change today | ▲ 0.45% | ▲ 3.52% |
| Market cap | $2.33T | $1.96T |
| Return, 3 months | +1.8% | +38.1% |
| Return, year to date | +48.4% | +16.9% |
| Return, 1 year | +61.0% | +1.5% |
| P/E (TTM) | 33.4 | 29.0 |
| P/B | 11.5 | 7.5 |
| P/E percentile vs own 5y | 83rd | 39th |
| Dividend yield | 0.77% | 0.27% |
| Revenue growth (YoY, latest qtr) | +36.0% | +28.0% |
| Net profit growth (YoY) | +77.8% | -13.6% |
| Gross margin | 64.2% | 81.7% |
| Operating margin | 56.1% | 38.1% |
| Net margin | 49.9% | 29.8% |
| Return on equity | 40.3% | 29.8% |
| Analyst target vs. price | +23.1% | -1.6% |
| Analyst buy share | 86% | 86% |
| RSI (14) | 60 | 77 |
| 30-day volatility | 28.7% | 45.9% |
| Max drawdown, 1 year | -21.5% | -32.5% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.